2019³â Á¦16ȸ °æÈñ½ÅÀå ¿¬¼ö°­Á ´ëÇѽÅÀåÇÐȸ »êÇÏ ÀüÇØÁú°íÇ÷¾Ð¿¬±¸È¸ ½ÉÆ÷Áö¾ö

ÀÏ ½Ã 2019³â 01¿ù 20ÀÏ(ÀÏ) ¿ÀÀü 09 ½Ã 00ºÐ - 16½Ã 00ºÐ
Àå ¼Ò °æÈñ´ëÇб³ Á¾ÇÕ°­Àǵ¿(û¿î°ü) ÁöÇÏ 1Ãþ ´ë°­´ç
Program Á¦16ȸ °æÈñ½ÅÀå ¿¬¼ö°­ÁÂ
Á¦1ºÎ
lgA nephropathy: Past, current and future
ÁÂÀå: ¹®ÁÖ¿µ(°æÈñ´ë),
È«¼ºÇ¥(È«¼ºÇ¥ ³»°ú)
09:00-09:20 Biomarker and precision medicine in lgA nephropathy Á¤°æÈ¯(°æÈñ´ë)
09:20-09:40 Recent update of pathology in lgA nephropathy ¼ºÁö¿¬(°æÈñ´ë)
09:40-10:00 Knowhow to manage the lgA nephropathy patients ÀÓõ±Ô(°æÈñ´ë)
10:00-10:30 Coffee Break  
Á¦2ºÎ
Real world in management of ESRD patients
ÁÂÀå: Á¤°æÈ¯(°æÈñ´ë),
¾ÈÀçÇü(ºÐ´ç¿­¸°ÀÇ¿ø)
10:30-10:50 How succefully manage the catheter dysfunction in HD patients? ȲÇö¼®(°æÈñ´ë)
10:50-11:10 Paricalcitol, cinacalcet and etelcalcetide: What is difference? ±è¾ç±Õ(°æÈñ´ë)
11:10-11:30 How to manage the failed graft after kidney transplantation? ÀÌÅ¿ø(°æÈñ´ë)
11:30-12:00 ÀÌÅ¿ø, ÀÓõ±Ô ±³¼ö Á¤³â ±â³ä½Ä  
12:00-13:00 Lunch Time  
 
Program ´ëÇѽÅÀåÇÐȸ »êÇÏ ÀüÇØÁú°íÇ÷¾Ð¿¬±¸È¸ ½ÉÆ÷Áö¾ö
Á¦1ºÎ
Clinical issues in electrolyte and hypertension
ÁÂÀå: ÀÌÅ¿ø(°æÈñ´ë),
±è±ÙÈ£(ÇѾç´ë)
13:00-13:20 Dialysate potassium, dialysate magnesium, and hemodialysis risk ±èÈ¿»ó(¿ï»ê´ë)
13:20-13:40 Ups and downs of dialysate calcium concentration in hemodialysis ÀÌ»óÈ£(°æÈñ´ë)
13:40-14:00 Automated blood pressure and CKD progression À¯ÅÂÇö(¿¬¼¼´ë)
14:00-14:20 Blood pressure targets for hemodialysis patients ÃÖÈ«»ó(Àü³²´ë)
14:20-14:40 Panel discussion
°í°­Áö(°í·Á´ë), ±è¼¼Áß(¼­¿ï´ë), °­¼±¿ì(ÀÎÀç´ë), ¹èÀºÈñ(Àü³²´ë)
 
14:40-15:00 Coffee Break  
Á¦2ºÎ
Interesting and educational cases
ÁÂÀå:±è¼ö¿Ï(Àü³²´ë),
ÃÖ¹ü¼ø(°¡Å縯´ë)
15:00-15:40 Case discussion  
15:40-16:00 Panel discussion
·ùµ¿¿­(ÀÌÈ­¿©´ë), À̼ҿµ(Â÷Àǰú´ë), ±è¼º±Õ(ÇѸ²´ë), ±è⼺(Àü³²´ë)